Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Interim Report Released on Real-World Safety of Fingolimod for Relapsing MS
Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium
Benemid: Discount Western Union Generic
Lymphopenia in treatment-naive relapsing multiple sclerosis.
Ultrasonic Elastography Evaluation in Optic Neuritis.
Pattern and motion-related visual-evoked potentials in neuroborreliosis: follow-up study.
Cytosolic phospholipase A2 plays a crucial role in ROS/NO signaling during microglial activation through the lipoxygenase pathway.
Cost of Drug-Related Monitoring Requirements for Glatiramer Acetate and Other Multiple Sclerosis Disease-Modifying Therapies (Dmts).
Vitamin D as a T-cell modulator in multiple sclerosis.
MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Stereological and flow cytometry characterization of leukocyte subpopulations in models of transient or permanent cerebral ischemia.
Treatment Effects for Dysphagia in Adults with Multiple Sclerosis: A Systematic Review.
Correction of Footdrop Due to Multiple Sclerosis Using the STIMuSTEP Implanted Dropped Foot Stimulator.
[Target Molecule for a Demyelinating Type of Guillain-Barré Syndrome, Acute Inflammatory Demyelinating Polyneuropathy].
The curtain is drawn for both natalizumab and fingolimod (FTY720): a new era of multiple sclerosis therapy has arrived.
Multiple sclerosis in families: risk factors beyond known genetic polymorphisms.
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: A pilot study.
JC Virus Infects Neurons and Glial Cells in the Hippocampus.
The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta.
Gilenya® data confirm reducing brain shrinkage matters for people with MS due to its association with long-term disability progression
Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis.
A qualitative investigation of exercising with MS and the impact on the spousal relationship.
Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis.
Acute pure motor demyelinating neuropathy with hyperreflexia and anti-GalNAc-GD1a antibodies.

Pages